Takashi Kusayama Selected Research

Adenosine (Adenocard)

3/2024

Target potential for ablation in adenosine-sensitive atrial tachycardia originating from the vicinity of the atrioventricular node identified by the LUMIPOINT software.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Takashi Kusayama Research Topics

Disease

4	Atrial Fibrillation 04/2024 - 01/2021
1	Tachycardia (Tachyarrhythmias) 03/2024
1	Heart Failure 01/2023
1	Hemorrhage 07/2022
1	Thromboembolism 07/2022
1	Fibrosis (Cirrhosis) 01/2021
1	Ganglion Cysts (Ganglion) 01/2021
1	Myocardial Infarction 03/2018
1	Reperfusion Injury 03/2018
1	Myocardial Ischemia (Ischemic Heart Diseases) 03/2018

Drug/Important Bio-Agent (IBA)

2	AnticoagulantsIBA 01/2023 - 07/2022
1	Adenosine (Adenocard)FDA LinkGeneric 03/2024
1	Warfarin (Coumadin)FDA LinkGeneric 07/2022
1	salicylhydroxamic acid (SHAM)IBA 01/2021
1	GAP-43 Protein (GAP 43 Protein)IBA 01/2021
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 03/2018
1	triphenyltetrazoliumIBA 03/2018
1	Evans Blue (Blue, Evans)FDA Link 03/2018
1	Phosphotransferases (Kinase)IBA 03/2018
1	Proteins (Proteins, Gene)FDA Link 03/2018
1	Selenoprotein PIBA 03/2018

Therapy/Procedure

3	Catheter Ablation 04/2024 - 01/2022
1	Therapeutics 01/2023
1	Electrodes (Electrode) 01/2021